SavedAdd your journal

Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2019 / Volume: 66 Issue: 4

Clinical approaches for genital and extragenital metastasis of transmissible venereal tumor in a bitch with ovarian remnant syndrome

Zeynep Günay Uçmak0000-0003-2530-1291
İsmail Kırşan0000-0003-0780-0118
Melih Uçmak0000-0002-8688-127X
Özge Erdoğan Bamaç0000-0002-0352-4841
Aydın Gürel0000-0002-0266-8771
Pages
—
Publication Date
2019-09-09
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that evaluation of the metastases with doppler ultrasonography will be favorable to reveal the hemodynamic alterations of related organs or tissues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 25 kg, 4 years old, Boxer breed bitch which had ovariohysterectomy section 2 years ago, was presented with weakness, loss of appetite, masses on abdominal and inguinal mammary glands and vaginal bleeding.
📊
Key Findings & Data:Transmissible venereal tumor (TVT) was diagnosed with vaginal cytology.
💡
Conclusion & Impact:It was concluded that evaluation of the metastases with doppler ultrasonography will be favorable to reveal the hemodynamic alterations of related organs or tissues.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Canine · metastasis · transmissible veneral tumor

Abstract

A 25 kg, 4 years old, Boxer breed bitch which had ovariohysterectomy section 2 years ago, was presented with weakness, loss of appetite, masses on abdominal and inguinal mammary glands and vaginal bleeding. Transmissible venereal tumor (TVT) was diagnosed with vaginal cytology. Intra-abdominal mass around the iliac artery and remnant ovary behind the right kidney were determined on ultrasonographic examination. The remnant ovary and the masses on mammary glands were removed by surgical approach. However, intra-abdominal mass could not be extirpated because of its localization during the same laparotomy. A biopsy was taken from the vaginal mass. According to histopathology, TVT and collagenous hamartoma were detected on mammary glands. Also, TVT was observed in vaginal and intra-abdominal masses. Chemotherapy protocol was arranged for intra-abdominal mass and vaginal TVT which occupied for ten weeks. Hemogram, vaginal smear and transabdominal ultrasonography were repeated before each chemotherapy course. Size of the intra-abdominal mass, pulsatility index (PI) and relative index (RI) values of iliac artery were evaluated with B-mode ultrasonography and doppler ultrasonography during the treatment, respectively. As a result, positive correlation between PI and RI values were determined. In the presented case, TVT and its metastases were successfully treated with both surgery and chemotherapy. It was concluded that evaluation of the metastases with doppler ultrasonography will be favorable to reveal the hemodynamic alterations of related organs or tissues.

🔖

Cite This Article

Uçmak, Z. G., Kırşan, İ., Uçmak, M., Bamaç, Ö. E., Gürel, A. (2019). Clinical approaches for genital and extragenital metastasis of transmissible venereal tumor in a bitch with ovarian remnant syndrome. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Volume: 66 Issue: 4. https://doi.org/10.33988/auvfd.568858

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (27)

  1. Amber EI, Henderson RA, Adeyanju JB, et al (1990): Single-drug chemotherapy of canine transmissible venereal tumour with cyclophosphamide, methotrexate or vincristine. J Vet Intern Med, 4, 144–147.
  2. Bartyzel BJ, Max A, Gruszczynska J, et al (2017): Hamartoma: a rare developmental disorder. Med Weter, 73(4), 202-207.
  3. Baştan A, Baki Acar D, Cengiz M (2008): Uterine and ovarian metastasis of transmissible venereal tumor in bitch. Turk J Vet Anim Sci, 32(1), 65-66.
  4. Behera SK, Kurade NP, Monsang SW, et al (2012): Clinico-pathological findings in a case of canine cutaneous metastatic transmissible venereal tumor. Vet Arhiv, 82(4), 401-410.
  5. Betamuzi EK (1992): Risk factors associated with canine TVT in Tanzania. Prevent Vet Med, 13, 13-17.
  6. Boscos CM, Ververidis HN (2004): TVT-Clinical findings, diagnosis and treatment. Proceedings of the 29th World Congress of the World Small Animal Veterinary Association.
  7. Castro KF, Strakova A, Tinucci-Costa M, et al (2017): Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil. Vet Comp Oncol, 15(2), 615-618.
  8. Champour M, Ojrati N, Nikrou A, et al (2014): First report of diffuse cutaneous canine transmissible venereal tumor in Iran. Comp Clin Pathol, DOI 10.1007/s00580-014-1973-z
  9. Çizmeci SÜ, Köse AM, Aydın İ, et al (2012): Transmissible venereal tümörlü dişi köpeklerde otojen aşı uygulaması. Eurasian J Vet Sci, 28(4), 220-223.
  10. Çizmeci SÜ, Köse AM, Aydın İ, et al (2012): Clinical efficiency of Doxorubicin and Cisplatin in treatment of transmissible venereal tumor of bitches. Revue Méd Vét, 163(11), 516-521.
  11. Das U, Das AK (2000): Review of canine transmissible venereal sarcoma. Vet Res Commun, 24, 545-556.
  12. Ferreira AJA, Jaggy A, Varejao AP, et al (2000): Brain and ocular metastases from a transmissible venereal tumour in a dog. J Small Anim Pract, 41, 165-168.
  13. Ganguly B, Das U, Das AK (2016): Canine transmissible venereal tumour: a review. Vet Comp Oncol, 14(1), 1-12.
  14. Gurel A, Kuscu B, Gulanber G, et al (2002): Transmissible venereal tumors detected in the extragenital organs of dogs. Israel J Vet Med, 57(2), 23-26.
  15. Jacob A, Bhanuprakash AG, Choudhary SS, et al (2015): Therapeutic management of transmissible venereal tumor in canine. Indian J Vet Med, 35(1), 81-85.
  16. Kevin AH (2002): Veterinary oncology: the practical veterinarian. Butterworth-Heinemann, Elsevier, USA.
  17. Liao KW, Lin ZY, Pao HN, et al (2003): Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. J Vet Diagn Invest, 15(5), 399-406.
  18. Mello Martins MI, Ferreira de Souza F, Gobello C (2005): The canine transmissible venereal tumor: Etiology, pathology, diagnosis and treatment. IVIS, A1233.0405.
  19. Nak D, Mısırlıoğlu D, Nak Y, et al (2004): Transmissible venereal tumor with mammary gland metastase in a bitch. Vet Bilimleri Derg, 20, 99–102.
  20. Nelson TR, Pretorius DH (1988): The doppler signal: where does it come from and what does it mean? Am J Roent, 151(3), 439-447.
  21. Ojeda J, Mieres M, Soto F, et al (2018): Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype. J Vet Int Med, DOI: 10.1111/jvim.15125.
  22. Purohit G (2008): Canine transmissible venereal tumor: A review. Internet J Vet Med, 6(1), 1-7.
  23. Richardson RC (1981): Canine transmissible venereal tumor. Comp Contin Educ Pract Vet, 3, 951-956.
  24. Turna Yılmaz O, Uçmak M, Gunay Z, et al (2013): Vaginal fold prolapse and transmissible venereal tumour related to ovarian remnant syndrome in a bitch: a case report. Vet Med, 58(12), 628-632.
  25. Turna O, Karabağlı M, Cetin AC, et al (2017): Metastasis of canine transmissible venereal tumor to median iliac lymph nodes and evaluation of treatment with computed tomography. Proceedings of 4th International VETIstanbul Group Congress.
  26. Uçar M (2016): Transmissible venereal tumor: a review. Kocatepe Vet J, 9(3), 230-235.
  27. Yang TJ (1988): Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma. Anticancer Res, 8(1), 93-95.